An alternative perspective on the management of status epilepticus

Epilepsy and Behavior

Volumn 12, Issue 3, 2008, Pages 349-353

  Beran, Roy G ^a,b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c LIVERPOOL HOSPITAL   (Australia)

Author keywords

Benzodiazepines; Carbamazepine; Convulsions; Levetiracetam; Midazolam; Seizures; Status epilepticus; Valproate

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; HARKOSERIDE; LORAZEPAM; MIDAZOLAM; NEW DRUG; PHENYTOIN; PROPOFOL; VALPROIC ACID;

ARTICLE; BRAIN INFECTION; CASE MANAGEMENT; DISEASE CONTROL; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; EPILEPSY; EPILEPTIC STATE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HOSPITAL ADMISSION; HUMAN; INJECTION SITE ABSCESS; INJECTION SITE NECROSIS; INTENSIVE CARE UNIT; MUSCLE NECROSIS; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; REPEATED DRUG DOSE; RESPIRATION DEPRESSION; SEIZURE; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT;

ANTICONVULSANTS; COMPLEMENTARY THERAPIES; HUMANS; SEIZURES; STATUS EPILEPTICUS;

EID: 40649121246     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2007.12.013     Document Type: Article

References (53)

1. Waterhouse E.J., and DeLorenzo R.J. Status epilepticus in older patients: epidemiology and treatment options. Drugs Aging 18 (2001) 133-142
2. Scott R.C., Surtees R.A.H., and Neville B.G.R. Status epilepticus: pathophysiology, epidemiology, and outcomes. Arch Dis Child 79 (1998) 73-77
3. Lowenstein D.H. It's time to revise the definition of status epilepticus. Epilepsia 40 (1999) 120-122
4. Waterhouse E.J. Status epilepticus. Curr Treat Options Neurol 4 (2002) 309-317
5. Prego-Lopez M., and Devinsky O. Evaluation of a first seizure: is it epilepsy?. Postgrad Med 111 (2002) 34-48
6. Nevander G., Ingvar M., Auer R., and Siesjo B.K. Status epilepticus in well-oxygenated rats causes neuronal necrosis. Ann Neurol 18 (1985) 281-290
7. Treatment of convulsive status epilepticus: recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993;270:854-859.
8. Walker M.C. Diagnosis and treatment of nonconvulsive status epilepticus. CNS Drugs 15 (2001) 931-939
9. Krumholz A. Epidemiology and evidence for morbidity of nonconvulsive status epilepticus. J Clin Neurophysiol 16 (1999) 314-322
10. Kaplan P.W. Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol 16 (1999) 341-352
11. Kellinghaus C., Dziewas R., and Ludemann P. Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature. Seizure 11 (2002) 243-249
12. Tasker R.C. Emergency treatment of acute seizures and status epilepticus. Arch Dis Child 79 (1998) 78-83
13. Staneveld E., and Staneveld A.A. Status epilepticus: current concepts and management. Can Fam Physician 46 (2000) 1817-1823
14. Treiman D.M. Convulsive status epilepticus. Curr Treat Opin Neurol 1 (1999) 359-369
15. Jagoda A., and Colucciello S.A. Seizures: accurate diagnosis and effective treatment. Emerg Med Pract 2 (2000) 2-24
16. Treiman D.M. Pharmacokinetics and chemical use of benzodiazepines in the management of status epilepticus. Epilepsia 30 Suppl. 2 (1989) S4-S10
17. Bassin S., Smith T.L., and Bleck T.P. Clinical review: status epilepticus. Crit Care 6 (2002) 137-142
18. Cock H.R., and Schapria A.H.V. A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. Q J Med 95 (2002) 225-231
19. Marik P.E., and Varon J. Management of status epilepticus. Chest 126 (2004) 582-591
20. Smith B.J. Treatment of status epilepticus. Neurol Clin 19 (2001) 347-369
21. Woods v Lowns & Procopis, Court of Appeal, 5/2/96 ref; 40094/1995.
22. Scott R.C., and Neville B.G.R. Pharmacological management of convulsive status epilepticus in children. Dev Med Child Neurol 41 (1999) 207-210
23. Lowenstein D.H. Status epilepticus. West J Med 168 (1998) 263
24. Lockey A.S. Emergency department drug therapy for status epilepticus in adults. Emerg Med J 19 (2002) 96-100
25. O'Sullivan C., and Harvey S. The use of rectal diazepam for the treatment of prolonged convulsions in children: consumer comments. Aust Prescr 21 (1998) 35-36
26. Bongard F.S., and Sue D.Y. Current critical care diagnosis & treatment. 2nd ed. (2002), Lange Medical Books/McGraw-Hill, New York p. 119
27. Scott R.C., Besag F.M.C., and Veville B.G.R. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet 353 (1999) 623-626
28. Galvin G.M., and Jelinek G.A. Midazolam: an effective intravenous agent for seizure control. Arch Emerg Med 4 (1987) 169-172
29. Durham D. Management of status epilepticus. Crit Care Resuscitation 1 (1999) 344-353
30. Lal Koul R., Raj Aithala G., Chacko A., Joshi R., and Seif Elbualy M. Continuous midazolam infusion as treatment of status epilepticus. Arch Dis Child 76 (1997) 445-448
31. Towne A.R., and DeLorenzo R.J. Use of intramuscular midazolam for status epilepticus. J Emerg Med 17 (1999) 322-328
32. Lahat E., Goldman M., Barr J., Bistritzer T., and Berkovitch M. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. Br Med J 321 (2000) 83-86
33. Blumer J.L. Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet 35 (1998) 37-47
34. Brevoord J.C., Joosten K.F., Arts W.F., van Rooij R.W., and de Hoog M. Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin. J Child Neurol 20 (2005) 476-481
35. Shorvon S. The management of status epilepticus. J Neurol Neurosurg Psychiatry 70 Suppl. 2 (2001) ii22-ii27
36. Walker M. Status epilepticus: an evidence based guide. Br Med J 331 (2005) 673-677
37. DeToledo J.C., and Lowe M.R. Seizures, lateral decubitus, aspiration, and shoulder dislocation: time to change the guidelines?. Neurology 56 (2001) 290-291
38. Howard R.S., Kullmann D.M., and Hirsch N.P. Admission to neurological intensive care: who, when, and why?. J Neurol Neurosurg Psychiatry 74 (2003) 2-9
39. Rosenow F., Arzimanoglou A., and Baulac M. Recent development in treatment of status epilepticus: a review. Epileptic Disord 4 Suppl. 2 (2002) S1-S11
40. Grant I.S., and Andrews P.J.D. Neurological support. Br Med J 319 (1999) 110-113
41. Webb T., and Cockerell C. Current role of drug treatment in the management of epilepsy. Prescriber 15 3 (2004) 54-60
42. Hart Y.M. Should first-line treatment of epilepsy differ for males and females?. J R Coll Physicians Edinb 33 Suppl. 11 (2003) 11-21
43. Nation R.L., Evans A.M., and Milne R.W. Pharmacokinetic drug interactions with phenytoin (Part 1). Clin Pharmacokinet 18 (1990) 37-60
44. Kanner A.M. The pharmacology of parenteral valproate. Epilepsy Curr 3 3 (2003) 109-111
45. Vajda F.J., Symington G.R., and Bladin P.F. Rectal valproate in intractable status epilepticus. Lancet 1 (1977) 359-360
46. Eadie M.J. Therapeutic drug monitoring: antiepileptic drugs. Br J Clin Pharmacol 46 (1998) 185-193
47. Patel N.C., Landan I.R., Levin J., Szaflarski J., and Wilner A.N. The use of levetiracetam in refractory status epilepticus. Seizure 15 (2006) 137-141
48. Beyenburg S., Bauer J., and Reuber M. New drugs for the treatment of epilepsy: a practical approach. Postgrad Med J 80 (2004) 581-587
49. Kenney P, Simpson J, Koch B. for the SP768 Study Group. A multi-center randomized double blind placebo controlled trial to assess the efficacy and safety of lacosamide (200, 400 and 600 mg/day) in subjects with painful distal diabetic neuropathy. In: Program and abstracts of the 25th Annual Scientific Meeting of the American Pain Society; May 3-6, 2006; San Antonio, Texas. Poster 774.
50. Curry W., and Kulling D. Newer antiepileptic drugs: gabapentin, lamotrigine, felbamate, topiramate and fosphenytoin. Am Fam Physician 57 (1998) 513-520
51. Leppik I.E. How to get patients with epilepsy to take their medication: the problem of noncompliance. Postgrad Med 88 (1990) 253-256
52. Senanayke N., and Peiris H. Mortality related to convulsive disorders in a developing country in Asia: trends over 20 years. Seizure 4 (1995) 273-277
53. Shorvon S.D., and Walker M.C. The treatment of tonic clonic status epilepticus. In: Duncan J.S., Sisodiya S.M., and Smalls J.E. (Eds). Epilepsy 2001: from science to patient. 8th ed. (2001), Meritus Communications, Edenbridge 331-336